PubMed:26456672 / 401-516 JSONTXT

{"project":"sentences","denotations":[{"id":"TextSentencer_T5","span":{"begin":0,"end":115},"obj":"Sentence"},{"id":"T5","span":{"begin":0,"end":115},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"This study valuated nitric oxide donors prophylactic treatment for preeclampsia in high-risk teenage primigravidae."}

{"project":"Preeclampsia","denotations":[{"id":"PD-Preeclampsia-B_T3","span":{"begin":67,"end":79},"obj":"ORPHA:275555"}],"namespaces":[{"prefix":"ORPHA","uri":"www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN\u0026Expert="}],"text":"This study valuated nitric oxide donors prophylactic treatment for preeclampsia in high-risk teenage primigravidae."}

{"project":"Preeclampsia-compare","denotations":[{"id":"PD-Preeclampsia-B_T3","span":{"begin":67,"end":79},"obj":"ORPHA:275555"}],"namespaces":[{"prefix":"ORPHA","uri":"www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN\u0026Expert="}],"text":"This study valuated nitric oxide donors prophylactic treatment for preeclampsia in high-risk teenage primigravidae."}